Nearly 20% of children are obese or overweight. It is anticipated half of childhood obesity will occur by age 5 and more than half of existing children will develop obesity by age 35. Maternal diet-derived nutritional signals transmitted during perinatal development condition metabolic responses later in life. We found high n-6 to n-3 (n6/n3) fatty acid exposures positively associate with increased infant body fat accumulation; and in mice, lowering n6/n3 exposure conditioned neonatal adipogenesis epigenetically, imparting long-lasting metabolic benefit to adults. Our findings led to the central hypothesis: Low n6/n3 exposure during development conditions adipogenesis via cellular and functional responses within stem-like adipocyte precursor populations. Adipocyte precursor cell (APC) subtypes include progenitors, preadipocytes, and newly discovered ?Adipogenesis-regulatory? cells (Areg). Aregs attenuate adipose tissue expansion (ATE) in a cell number and paracrine way. Importantly, we observe attenuated neonatal body fat accumulation, morphology, and cellularity from low n6/n3 exposure in mice. This phenotype supports that patterning of ATE is sensitive to early life n6/n3, yet, the APC subtype frequencies and molecular diversity regulated by low n6/n3 stimuli remain unknown. We began addressing this gap by isolating primary APCs from fat depots of pups with high and low n6/n3 exposure. Preliminary bulk RNA-seq analysis identified increased Areg subtype markers from low n6/n3 exposure. Included is NR2F2 -a key transcriptional regulator linked to attenuated adipogenesis. In co-culture, APCs conditioned in vivo by low n6/n3 proliferated slower and differentiated less. These findings suggest increases Areg cell number (or their activity) might attenuate detrimental ATE in neonates. This proposal combines state-of-the-art single cell RNA-sequencing, modern flow cytometry techniques, genetic manipulation of n6/n3 ratios and NR2F2, real-time live cell imaging, and in vitro primary APC culture to achieve two primary objectives: SA1. To quantify Areg cell number simultaneously with Areg specific mRNA signatures triggered by high and low n6/n3 postnatal exposures. SA2. To determine if NR2F2 mediates the low n6/n3 dependent effect on in vivo adipogenesis, APC populations, and APC adipogenic potential. Impact. Defining molecular responses and cellular diversity of APC subtypes that can condition early life ATE in vivo could help inform new modalities of obesity prevention.

Public Health Relevance

- Obesity incidence has quadrupled for adolescents and now affects ~20% of youth in the U.S., leading to adult metabolic-related diseases including type-2-diabetes, heart disease, and some types of cancer that burden our medical and insurance systems, and reduce the individual?s quality of life and psychological wellbeing. Understanding the molecular, cellular and functional roles that unique subtypes of stem- like adipocyte precursor cells play in patterning early life fat depot growth will uncover new strategies for obesity prevention as adults, such as therapeutics that can bolster beneficial adipocyte precursor types.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Small Research Grants (R03)
Project #
1R03DK122189-01
Application #
9807608
Study Section
Kidney, Urologic and Hematologic Diseases D Subcommittee (DDK)
Program Officer
Saslowsky, David E
Project Start
2019-08-01
Project End
2021-05-31
Budget Start
2019-08-01
Budget End
2020-05-31
Support Year
1
Fiscal Year
2019
Total Cost
Indirect Cost
Name
University of Colorado Denver
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
041096314
City
Aurora
State
CO
Country
United States
Zip Code
80045